Phibro Animal Health Corporation (NASDAQ:PAHC) was downgraded by stock analysts at ValuEngine from a “buy” rating to a “hold” rating in a report released on Thursday.

PAHC has been the topic of several other research reports. Credit Suisse Group lifted their target price on Phibro Animal Health Corporation from $36.00 to $37.00 and gave the company an “outperform” rating in a research note on Thursday, August 31st. Zacks Investment Research lowered Phibro Animal Health Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Piper Jaffray Companies restated a “buy” rating and set a $41.00 price target (down previously from $42.00) on shares of Phibro Animal Health Corporation in a research note on Thursday, August 31st. BidaskClub lowered Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 23rd. Finally, Bank of America Corporation restated an “underperform” rating and set a $33.00 price target on shares of Phibro Animal Health Corporation in a research note on Wednesday, August 23rd. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $38.25.

Phibro Animal Health Corporation (NASDAQ PAHC) traded up $0.45 during trading hours on Thursday, hitting $34.60. The stock had a trading volume of 74,500 shares, compared to its average volume of 78,865. Phibro Animal Health Corporation has a fifty-two week low of $26.10 and a fifty-two week high of $40.25. The company has a market capitalization of $1,380.09, a P/E ratio of 22.61, a price-to-earnings-growth ratio of 4.06 and a beta of 1.35. The company has a debt-to-equity ratio of 1.91, a quick ratio of 1.75 and a current ratio of 3.26.

Phibro Animal Health Corporation (NASDAQ:PAHC) last released its quarterly earnings data on Monday, November 6th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.01. The firm had revenue of $193.40 million during the quarter, compared to the consensus estimate of $189.89 million. Phibro Animal Health Corporation had a return on equity of 42.75% and a net margin of 8.87%. The firm’s quarterly revenue was up 2.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.36 earnings per share. analysts forecast that Phibro Animal Health Corporation will post 1.57 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Phibro Animal Health Corporation (PAHC) Stock Rating Lowered by ValuEngine” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/11/12/phibro-animal-health-corporation-pahc-stock-rating-lowered-by-valuengine.html.

In related news, insider Dean J. Warras sold 10,000 shares of Phibro Animal Health Corporation stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $35.70, for a total transaction of $357,000.00. Following the completion of the sale, the insider now owns 10,000 shares of the company’s stock, valued at $357,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Larry Lee Miller sold 15,891 shares of Phibro Animal Health Corporation stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $36.46, for a total value of $579,385.86. Following the sale, the chief operating officer now directly owns 15,891 shares of the company’s stock, valued at approximately $579,385.86. The disclosure for this sale can be found here. Insiders have sold 292,448 shares of company stock valued at $10,624,994 in the last ninety days. Corporate insiders own 51.88% of the company’s stock.

A number of large investors have recently made changes to their positions in the business. Alps Advisors Inc. lifted its holdings in Phibro Animal Health Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 17,541 shares of the company’s stock valued at $650,000 after acquiring an additional 46 shares during the period. Louisiana State Employees Retirement System lifted its holdings in Phibro Animal Health Corporation by 1.3% in the second quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock valued at $282,000 after acquiring an additional 100 shares during the period. Arizona State Retirement System lifted its holdings in Phibro Animal Health Corporation by 1.0% in the second quarter. Arizona State Retirement System now owns 9,800 shares of the company’s stock valued at $363,000 after acquiring an additional 100 shares during the period. Nationwide Fund Advisors lifted its holdings in Phibro Animal Health Corporation by 1.0% in the second quarter. Nationwide Fund Advisors now owns 10,866 shares of the company’s stock valued at $403,000 after acquiring an additional 110 shares during the period. Finally, Municipal Employees Retirement System of Michigan lifted its holdings in Phibro Animal Health Corporation by 3.6% in the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after acquiring an additional 150 shares during the period. 49.87% of the stock is owned by institutional investors.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Receive News & Stock Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related stocks with our FREE daily email newsletter.